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Abstract
Background: HMO databases offer an opportunity for community based epidemiologic studies of
asthma incidence, etiology and treatment. The incidence of asthma in HMO populations and the
utility of HMO data, including use of computerized algorithms and manual review of medical charts
for determining etiologic factors has not been fully explored.
Methods:  We identified adult-onset asthma, using computerized record searches in a New
England HMO. Monthly, our software applied exclusion and inclusion criteria to identify an "at-risk"
population and "potential cases". Electronic and paper medical records from the past year were
then reviewed for each potential case. Persons with other respiratory diseases or insignificant
treatment for asthma were excluded.
Confirmed adult-onset asthma (AOA) cases were defined as those potential cases with either new-
onset asthma or reactivated mild intermittent asthma that had been quiescent for at least one year.
We validated the methods by reviewing charts of selected subjects rejected by the algorithm.
Results: The algorithm was 93 to 99.3% sensitive and 99.6% specific. Sixty-three percent (n = 469)
of potential cases were confirmed as AOA. Two thirds of confirmed cases were women with an
average age of 34.8 (SD 11.8), and 45% had no evidence of previous asthma diagnosis. The
annualized monthly rate of AOA ranged from 4.1 to 11.4 per 1000 at-risk members. Physicians
most commonly attribute asthma to infection (59%) and allergy (14%). New-onset cases were more
likely attributed to infection, while reactivated cases were more associated with allergies. Medical
charts included a discussion of work exposures in relation to asthma in only 32 (7%) cases. Twenty-
three of these (72%) indicated there was an association between asthma and workplace exposures
for an overall rate of work-related asthma of 4.9%.
Conclusion: Computerized HMO records can be successfully used to identify AOA. Manual
review of these records is important to confirm case status and is useful in evaluation of provider
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consideration of etiologies. We demonstrated that clinicians attribute most AOA to infection and
tend to ignore the contribution of environmental and occupational exposures.
Background
Asthma is a seriously debilitating and sometimes life-
threatening disease that affects more than 8 million adults
in the United States. [1] The incidence, prevalence and
mortality of this disease appear to be increasing, as does
the incidence of occupational asthma. [2–5] Estimates of
incidence rates of asthma in adults range between 0.5–
4.1/1,000 at-risk per year. [5–7]
Health maintenance organization (HMO) member popu-
lations offer a unique opportunity for community-based
epidemiologic studies of asthma. [8–12]
Computerized HMO data have been successfully used to
study asthma, though most research has focused on prev-
alence or drug therapy. Donahue and colleagues con-
ducted a study using automated medical records from an
HMO in eastern Massachusetts to determine the reliability
of identifying asthmatics and determining severity of
asthma in computerized medical and pharmacy records.
[10] They conducted a review of full text medical records
on a random sample of identified cases to validate asthma
diagnosis and to extract clinical information that was used
to assess asthma severity. Full text medical record review
demonstrated a positive predictive value of 86% for those
identified by the automated method for coded asthma
diagnosis, but researchers found limited utility of these
data to assess disease severity. They demonstrated modest
agreement between computerized and manual methods
to determine incident versus prevalent asthma (kappa =
0.5) and that occupation was noted in only 19% of
records reviewed.
Our study provides additional evidence that computer-
ized data in HMO systems can be used successfully to
measure asthma incidence; that review of clinical data
from staff model HMO medical records is valuable in con-
firming asthma diagnosis, when using computerized algo-
rithms for case identification; and that HMO medical
records can provide some detail on the evaluation of med-
ical care and how often clinicians document and use rele-
vant information on etiologic factors, including relevant
workplace exposures.
In this paper we report the incidence of AOA (both new-
onset and a reactivated asthma) in a New England HMO.
We also evaluate the usefulness of conducting reviews of
medical records to validate case status and report the fre-
quency that clinicians obtained and used relevant etio-
logic data for cases.
Methods
Study population
Fallon Community Health Plan (FCHP) provides health
care services through the Fallon Clinic, a centralized
organization that provides the full range of services to
FCHP members with over 300 physicians working at
more than 30 ambulatory care centers in central Massa-
chusetts. In 2000, it served approximately 190,000 peo-
ple. Virtually all (99%) FCHP members are enrolled
without health screening either through employer-based
programs (83%) or Medicaid and Medicare contracts
(16%). Thus, there are no health-based barriers to mem-
bership for employed persons and their families. Fallon is
offered by about 3,500 employers. Most of the self-pay
members have converted temporarily to this status on
leaving employment. In addition, the clinic offers fee-for-
service medical care to non-members.
Case identification
This investigation was reviewed and approved by the Fal-
lon Institutional Review Board, as well as the Harvard
School of Public Health Human Subjects Committee.
Software to query the HMO's Oracle® data warehouse of
coded outpatient encounter forms and inpatient and
referral claims was developed and a study algorithm was
designed to identify potential cases of adult-onset asthma
(AOA) similar to a previously described algorithm used
on an older computer system [Milton, 1998]. Automated
searches were performed on a monthly basis. For each
month, the algorithm first applied membership criteria to
obtain eligible members, followed by exclusion criteria to
identify an at-risk population, and finally by inclusion cri-
teria to identify potential cases.
Data for each month were first queried approximately 2
weeks after the last day of the month, and queried
monthly thereafter for 6 months to ensure that late-arriv-
ing claims data were included. The membership criteria
ensured that the study population had comparable qual-
ity of information by requiring that eligible members for
a given month (the index month) a) had at least 6 months
of HMO membership with no gap of more than 45 days
in coverage prior to the index month and b) had been a
member for the entire index month. Because inclusion
and exclusion criteria were based on prescription informa-
tion and were confirmed by chart review, the study popu-
lation was also restricted to those members with plan
types that included pharmacy benefits and primary care
delivered through the staff model portion of the HMO –
the Fallon Clinic. Enrollment in the cohort was open toEnvironmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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ensure that new members were included six months after
joining the health plan and that they contributed person
time to the study until termination of insurance coverage.
Males and females between ages 15 and 55 were eligible
for inclusion in the study population.
Exclusion criteria (Table 1) were applied in the computer-
ized search of encounter forms, claims, and pharmacy
data from the twelve months (reference period) prior to
each index month to define the "at-risk" population.
Exclusion criteria were designed to remove members with
prevalent asthma and various co-morbid conditions such
as bronchitis, chronic bronchitis, chronic obstructive pul-
monary disease, chronic and acute pulmonary heart dis-
ease, and pulmonary hypertension from the "at-risk"
population. Prevalent asthma was defined as having a
record of asthma admission, by dispensing of second line
medications, or an outpatient visit for asthma with either
a nebulization treatment, or dispensing of oral steroids or
more than four metered dose inhalers.
The final step in the algorithm applied several inclusion
criteria to computerized records regarding the "at-risk"
population for the current (index) month to identify the
"potential cases", all of which were subjected to a medical
chart review by trained research nurses and/or a respira-
tory epidemiologist. The inclusion criteria included an
emergency room visit or hospital admission with a pri-
mary diagnosis of asthma, diagnosis of occupational
asthma or an outpatient asthma diagnosis in conjunction
with clinically significant pharmacological treatment for
asthma (Table 2). AOA was defined as an asthma case,
verified by manual chart review, who either had onset of
asthma (with no prior history of asthma) or reactivation
of asthma that had been quiescent for at least one year.
Chart review
Confirmation of case status by manual review of the med-
ical record was incorporated into the study design to pro-
vide specificity so that initial case identification by the
computerized algorithm would be highly sensitive. Medi-
cal records (both electronic and hard-copy charts) of all
potential cases were reviewed by a trained research nurse
and the findings recorded in a computerized database.
Three percent of charts were either missing or had insuffi-
cient data on which to determine asthma status. The chart
review covered a 13-month period, beginning with the
month of selection into the cohort (index period) fol-
lowed by review of the 12 months preceding that date
(reference period). Records for the index period were
reviewed to identify and evaluate the adequacy of a case-
defining event. We considered an adequate case-defining
event to exist when a physician recorded an asthma diag-
nosis in the written record, and there was clinically signif-
icant asthma treatment prescribed and ordered within a
month of the diagnosis. The chart reviewer also looked for
exclusion criteria by reviewing the medical records for the
reference period. A case was confirmed when a subject
met any of the inclusion criteria during the index period
without meeting any exclusion criterion during the 12
months prior. Asthma severity was used to define the
distribution of asthma cases that were selected by the
computerized algorithm and to evaluate the accuracy of
the algorithm. It also assisted with proper AOA case
identification. Asthma severity was assessed using
National Heart, Lung and Blood Institute guidelines
adapted for use with the information available in the
medical record (Table 3). [1]
In addition to evaluation of inclusion and exclusion crite-
ria, the chart reviewer recorded several other factors to the
extent that they appeared in the chart during the time
interval covered by the chart review. These included: the
Table 1: Exclusion criteria used to identify at-risk population*
Description ICD-9 (CPT) Codes†
1 Heart Failure 428–428.9
2 Bronchitis, chronic bronchitis, and emphysema 490–492.8
3 Pulmonary hypertension, embolism and other pulmonary heart disease 415–416.9
4 Chronic obstructive pulmonary disease 496
5 ER visit or hospital admission for primary asthma diagnosis 493–493.91
6 Occupational asthma diagnosis 504–507, 495.8, 507.8
7 Asthma diagnosis AND outpatient nebulization treatment 493–493.91 AND (94640)
8 Ordered second line asthma medications‡
9 Any asthma diagnosis AND ordered oral steroids 493–493.91
10 Asthma diagnosis AND ordered 4 or more MDIs¶ 493–493.91
* Exclusion criteria were applied to records for the 12 months preceding the index month. †International Classification of Diseases 9th Edition and 
Current Procedural Terminology codes; ‡ Second line medications included cromolyn, necrodomyl, aerosolized steroids, theophylline, oral or 
nebulized Beta-agonists, and leukotriene inhibitors; ¶MDI= Beta-agonist metered dose inhaler.Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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physician's level of documentation and certainty of
asthma diagnosis, presence and result of methacholine
challenge testing, etiology of asthma as recorded by prac-
titioners, presence and relevant content of an annual
physical examination, prescription of respiratory medica-
tions, pulmonary tests ordered in the past year (spirome-
try, serial peak expiratory flows), history of childhood
asthma, height, weight and demographic information.
The presence of notes that evaluated symptoms in relation
to home, work and environmental exposures were also
recorded along with the type of practitioner making the
record.
To measure the sensitivity of the computerized records
search, we performed an additional analysis to identify
possible adult-onset asthma cases that may have been
missed by our algorithm. We therefore, focused on eligi-
ble members with asthma diagnoses to increase the possi-
bility of identifying cases that may have been excluded in
error. We first applied our exclusion and inclusion criteria
and performed chart reviews as described above. We then
made a second run over the data with altered exclusion
criteria so that we did not exclude persons with prior
asthma or acute bronchitis; thus, obtaining an at-risk pop-
ulation containing all asthmatics who did not have heart
failure, chronic bronchitis, emphysema, chronic obstruc-
Table 2: Inclusion criteria used to identify adult-onset asthma cases*
Criteria ICD-9 (CPT) Codes†
1 Asthma diagnosis AND outpatient nebulization treatment 493–493.91 AND (94640)
2 Any asthma diagnosis AND ordered oral steroids 493–493.91
3 Any asthma diagnosis AND a second line medication‡ 493–493.91
4 ER visit OR hospital admission for primary asthma diagnosis 493–493.91
5 Asthma diagnosis AND ≥ 2 MDIs¶ 493–493.91
6 Occupational asthma diagnosis 504–507, 495.8, 507.8
* Inclusion criteria were applied to records during the index month, † ‡ ¶See Table 1
Table 3: Categories for classifying potential cases selected for chart review
Classification of Asthma Severity
Symptoms Night time Symptoms Lung Function Chart Review
Mild Intermittent • Symptoms ≤ 2 times/week ≤ 2 times a month • FEV1 or PEF ≥ 80% predicted Asthma not mentioned in visits that are 
routine (i.e. physical exam) or for other 
medical problems. Does not refill 
asthma medications regularly.
• Asymptomatic and normal PEF 
between exacerbations
• PEF variability < 20%
• Exacerbations brief (from a few hours 
to a few days); intensity may vary
Mild Persistent • Symptoms > 2 times a week but < 1 
time a day
> 2 times a month • FEV1 or PEF ≥ 80% predicted Asthma mentioned in some of the 
"non-asthma" visits. Asthma meds 
refilled regularly. Exacerbation may 
require systemic steroids.
• Exacerbations may affect activity • PEF variability 20–30%
Moderate Persistent • Daily Symptoms > 1 time a week • FEV1 or PEF >60% -<80% predicted Asthma is a common reason for visits. 
Uses inhaled steroids regularly. Uses 
systemic steroids intermittently, but 
more than once a year in most years.
• Daily use of inhaled short-acting 
beta2-agonist
• PEF variability >30%
• Exacerbations affect activity
• Exacerbations ≥ 2 times a week; may 
last days
Severe Persistent • Continual symptoms Frequent • FEV1 or PEF ≤ 60% predicted Asthma always a problem. Systemic 
steroids frequently or continuously. 
Hospitalizations.
• Limited physical activity • PEF variability >30%
• Frequent exacerbations
Adapted from NHLBI "Guidelines for the diagnosis and management of asthma". NIH publication number 97-4051, July 1997.Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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tive lung disease, pulmonary hypertension, embolism, or
other pulmonary heart disease. From this group, we
excluded all cases accepted after the chart review described
above. We then applied our inclusion criteria, except that
we altered criterion number 5 so that at-risk members
with an asthma diagnosis and one MDI were included. All
charts of the new cases so identified were subjected to
chart review.
Data analysis
Chart reviews were recorded in Microsoft Access file for-
mat using a computerized questionnaire system (CSESC,
Boston, MA) and converted into SAS datasets (version 8,
SAS Institute, Cary, NC) for data analysis using SAS Proc
Freq and SAS Proc Means. EpiInfo6 and Statcalc were used
to calculate relative risks and confidence intervals.
Results
Summary of cohort and incidence data
The monthly average eligible population consisted of
61,892 HMO members including 55,905 at-risk of devel-
oping asthma. The monthly, computerized searches iden-
tified 746 potential cases for the 12-month period March
2000 through February 2001. On average, 62 potential
cases were identified each month and 39 were confirmed
by chart review. The incidence of confirmed AOA varied
by month and trends for new-onset and reactivated
asthma were similar (Figure 1). The incidence over the
one-year study period was 3.8 per 1000 persons for new-
onset cases, 4.6 per 1000 for reactivation of asthma after
at least one year of inactivity and 8.4 per 1000 combined.
Overall, three seasonal AOA peaks were observed in the
combined (new onset and reactivation) annualized rates:
May – June, September – October, and January–February.
July and August had the lowest combined AOA incidence
rates. Rates of new onset and reactivation were roughly
equal in August through October 2000. Reactivation rates
were greater than new onset rates from March through
July 2000 and in January 2001. New onset rates were
greater than reactivation rates during the months of
November, December 2000 and February 2001.
Validation of computerized exclusions and inclusions
We performed several analyses using chart reviews of both
paper and electronic medical records to determine the
validity of the exclusion and inclusion of HMO members
as executed by the computerized algorithm. The validity
necessarily depends on the quality of the data in the com-
puter system, and the evaluation depends on the com-
pleteness of data in the hard copy medical record and
electronic doctors' notes used for comparison. Initial tests
of validity included chart reviews for randomly selected
Annualized adult-onset asthma incidence-March 2000–February 2001 Figure 1
Annualized adult-onset asthma incidence-March 2000–February 2001Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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charts of excluded members. No erroneously excluded
members were found.
To determine the sensitivity of the computerized records
search for AOA, we examined data from an overlapping
study of prevalent asthmatics from the same HMO during
the ten-month period September 2000 to June 2001. The
computer search for prevalent asthmatics included all per-
sons, who did not have a chronic disqualifying ailment
other than asthma and had not been included in the AOA
study, but who had a computer record of asthma treat-
ment during this time period. There were an average of
59,920 eligible members during this time period and an
at-risk population of 54,090 for the AOA study with 629
potential and 399 accepted AOA cases after chart review.
There were 85 persons identified by the computer search
for prevalent asthma identified who were not identified
by the search for AOA. Review of these charts showed that
82 had persistent asthma, mild intermittent asthma
without exacerbation, or were judged as not asthma based
on chart review. Three of the 85 cases met our criteria for
adult-onset asthma.
We estimated sensitivity and specificity of the computer
search for AOA by assuming that the 3 cases identified as
erroneously excluded represented all of such cases. Under
this assumption, the computer algorithm for possible
adult-onset asthma was 99.3% (399/402) sensitive and
99.6% (59,288/59,518) specific. Even if we were to
assume that these 3 cases only accounted for 10% of erro-
neously excluded cases, the sensitivity of the computer
algorithm remains high (93%). However, the positive pre-
dictive value of the computer algorithm was only (399/
629) 63% during the ten month validation period.
During the one year of complete data collection reported
here, sixty-three percent (n = 469) of all potential cases
identified by the computer algorithm were confirmed by
chart review. The confirmation rates for each of the six
inclusion criteria are shown in Table 4. The most specific
inclusion criteria were asthma diagnosis with a nebulizer
treatment (80%), and asthma diagnosis with a prescrip-
tion for oral steroids (66%). Asthma status in the 12
months prior to the index month was also assessed by
chart review and is shown in Table 5. The majority of cases
rejected by chart review had persistent asthma with symp-
toms during the previous 12 months (n = 100), weak evi-
dence of asthma (n = 58) or mild intermittent asthma
with no exacerbation during the index month (n = 35).
One potential case with new-onset asthma and 20 poten-
tial cases classified as mild intermittent asthma had co-
morbid lung conditions or significant asthma treatment
in the previous 12 months that had not been captured by
the computerized records search.
Observations on adult-onset asthma
Approximately two-thirds of all confirmed cases of adult-
onset asthma were women with an average age of 34.8
(SD 11.8) (Table 5). The average age in males was similar
(34.6; SD 12.2). Overall, clinicians attributed asthma
onset in most cases (59%) to infection (Table 6). New-
onset cases however, were more likely to be attributed to
infection (RR = 1.4, 95% C.I. 1.2, 1.6) than were reacti-
vated cases, and less likely to be attributed to allergies (RR
= 0.54, 95% C.I. 0.32, 0.89). Ten percent of cases had a
history of childhood asthma (based on notes in the med-
ical records from the last 13 months), and an additional
18 percent had notes indicating asthma onset more than
a year before the case-defining event.
Peak expiratory flow rates, the most frequently recorded
measure of pulmonary function in the year prior to case
identification, were performed by 39% (n = 181) of
accepted cases. Spirometry was recorded in only 2% (n =
11) of cases while spirometry pre- and post-bronchodila-
tor was slightly less frequent (1.5%, n = 7). Methacholine
challenge testing was administered to 1 case.
Provider Consideration of Exposures in Confirmed Cases
Providers noted potential environmental/outdoor, home
and occupational exposures in notes about asthma in
only a small fraction of cases (Table 7). When noted,
Table 4: Case confirmation rates by algorithm inclusion criteria
Criteria Potential Cases Confirmed Cases
N%
Asthma diagnosis AND outpatient nebulization treatment 185 148 80
Any asthma diagnosis AND ordered oral steroids 156 105 67
Any asthma diagnosis AND a second line medication‡ 305 175 57
ER visit OR hospital admission for primary asthma diagnosis 38 20 53
Asthma Diagnosis AND ≥ 2 MDIs¶ 49 18 37
Occupational asthma diagnosis 13 3 23
Total 746 469 63Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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however, environmental/outdoor and home exposures
were reported as asthma triggers (but not necessarily
causal agents) in 72% and 66% of respective cases. Of
patients asked about work-related exposures, 72% were
noted to have work-related asthma (4.9% of all AOA).
Occupation was recorded at sometime during the 13-
month interval covered by the chart review for 22% of
AOA patients. Of the 23 with patients whose charts indi-
cated that they had work-related asthma, three were coded
by providers on encounter forms as having occupational
asthma and two of these were seen by an occupational
medicine specialist.
Discussion
This study demonstrates that we can successfully identify
adult-onset asthma in HMO data with high sensitivity and
specificity, but that the high sensitivity is gained at the
expense of a relatively low predictive value positive –
necessitating manual chart review of potential cases.
Table 5: Demographics and asthma status for potential, excluded and confirmed cases
Potential Cases Excluded Cases Confirmed Cases
Female n, (%) 483 (65) 176 (64) 307 (66)
Age, female mean (SD) 34.4 (12) 33.5 (12) 34.8 (12)
Males 263 (35) 101 (37) 162 (35)
Age, male mean (SD) 34.2 (12) 33.6 (12) 34.6 (12)
Asthma Status Prior to Index Month n, (%)
No Prior Asthma 211 (28) 1 (<1%) 210 (45)
Mild Intermittent, Inactive 279 (37) 20 (7) 259 (55)
Mild Intermittent, Active 39 (5) 39 (14) 0
Mild Persistent with Exacerbation 62 (8) 62 (22) 0
Mild Persistent 31 (4) 31 (11) 0
Moderate Persistent 7 (1) 7 (3) 0
Weak Evidence 58 (8) 58 (21) 0
No Evidence 35 (5) 35 (13) 0
Insufficient Data 24 (3) 24 (9) 0
Total 746 277 469
Table 6: Clinician assessment of cause of asthma onset
Cause of Morbidity* Total Cases, N (%) New-onset Cases N (%) Reactivated Cases N (%) Relative Risk,** [95% C.I.]
Infection Induced 275 (59) 144 (70) 131 (51) 1.4, [1.2, 1.6]
Allergy Induced 63 (14) 19 (9) 44 (17) 0.54, [0.32, 0.89]
Exercise Induced 20 (4) 9 (4) 11 (4) 1.02, [0.43, 2.41]
Other 23 (5) 12 (6) 11 (4) 1.36, [0.61, 3.02]
No Etiology Given 84 (18) 23 (11) 61 (24) 0.47, [0.30, 0.73]
Total 465* 207 258
*4 missing observations **Unadjusted Relative Risk, New-onset cases versus reactivated cases with reference group representing all other etiologic 
categories combined, including "no etiology given"
Table 7: Frequency of exposures mentioned in medical records of confirmed cases.
Occupational Exposures, N (%) Home Exposures, N (%) Environmental/Outdoor 
Exposures, N (%)
Confirmed cases with noted exposure 32 (7)* 53 (11) 61 (13)
Positive Association Noted 23 (72)** 35 (66) 44 (72)
*Percent of all confirmed cases (n = 469). **Percent of confirmed cases with positive association noted for respective exposuresEnvironmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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These data also suggest that chart review is necessary to
distinguish between new-onset and reactivated asthma.
An earlier study conducted by Donahue and colleagues
[10] focused on measuring disease severity for analysis of
quality of care but did not present results on the sensitivity
and specificity of their automated search. Their finding
that manual review of medical records, combined with an
automated search of HMO data were necessary to distin-
guish between incident and prevalent asthma is consistent
with ours.
Our data show that clinicians tend to overlook or at the
very least, fail to document the potential contributions of
environmental and occupational etiology in most cases.
Occupational asthma incidence rates are sparse in studies
conducted in the United States. In addition, there has long
been anecdotal evidence that physicians do not ade-
quately assess the work-relatedness of many diseases,
including asthma. These data support that claim. Dona-
hue's study similarly demonstrated that common sources
of asthma incitants (pets, passive smoke, workplace expo-
sures) were rarely documented in medical records of asth-
matics. They show that occupation was noted in 19% of
reviewed cases.
The overall incidence of new-onset asthma and asthma
reactivation in adults in this population were higher dur-
ing the period of observation reported here from March of
2000 through February of 2001 (3.8/1,000 for new-onset
asthma and 4.6/1,000 for reactivated asthma) than the
rate observed in the three-month pilot study in 1995 (1.3/
1,000 for new-onset asthma and 2.4/1,000 for reactivated
asthma). [12] There appears to be almost a three-fold
increase in the new-onset cases and a two-fold increase in
reactivated cases of asthma. This increase persists when
considering only the same three months observed in the
pilot study (July through September), though it is some-
what less strong, especially for reactivated asthma. There
are many possible explanations for this observation. The
two to three-fold interval change in rates may represent
improved or more complete data capture by the data
warehouse compared with older computer systems used
previously, and cannot be attributed to increased inci-
dence alone.
Epidemiologic investigations typically demonstrate
higher rates of asthma later in life in women than in men,
as seen in these data. [13–15] The mean age at onset of
AOA within the studied age range does not differ between
men and women.
Our findings regarding the very small number of cases
who had evidence of spirometry with or without pre- and
post-bronchodilator testing or methacholine challenge
testing was also consistent with the observations of Don-
ahue and colleagues. [10] They report that spirometry was
associated with only one percent of encounters. Peak
expiratory flow measurement, however, was reported
more frequently in this population than that observed by
Donahue et al. (39% versus 4%). The reason for this is
unclear. It is possible that review of hard copy charts con-
ducted at Fallon provides more complete data with
regards to peak expiratory flow rates often used in urgent
care centers to evaluate the effectiveness of nebulizer treat-
ments. There could well be cultural differences between
HMO's and incentives for recording various treatments.
In general, clinicians attributed AOA primarily to infec-
tion and less often to allergy. Annualized rates of new
onset asthma were greater during the fall and winter
months (September through February). This may repre-
sent the influence of certain infections during the winter
months on new-onset cases consistent with the clinical
attribution of most new onset cases to infection. On the
other hand, the months with peak reactivation rates in
May through June suggest that allergies may play a more
important role in reactivation, consistent with the clinical
impressions recorded by providers. Alternatively, the
National Heart, Lung and Blood Institute's effort to
increase the use of lung function testing to improve
proper diagnosis of asthma may have had an impact over
the 10 years since the Donahue data were collected. [16]
It appears that providers seldom recorded information
about occupation in notes on asthma unless they consid-
ered the symptoms triggered by workplace exposures.
Records indicated that only 7% of members with AOA
were asked about work-related exposures in relation to
asthma symptoms, but because 72% of these were
reported as having an association with work it seems
likely that clinicians asked more often but seldom docu-
mented it unless the answer was positive. Home, outdoor
and other environmental exposures were also rarely
recorded or discussed by providers. If recorded, these
exposures were also likely to be reported as being related
to symptoms. Although not surprising, it is nevertheless
disappointing to find such a dearth of exposure informa-
tion noted in medical charts. It seems providers do not
have a thorough or systematic approach to evaluating var-
ious exposures in relation to new asthma symptoms. It is,
however possible that providers only record positive asso-
ciations or asthma triggers in medical notes and disregard
areas that may have been discussed but seemed not to
bear a causal or exacerbating role.
Almost 5% of adult-onset asthma cases were recognized as
having work-related symptoms. This gives an annual
work-related symptoms incidence among adult-onset
cases of 40/100,000 HMO members. This places a lower-Environmental Health: A Global Access Science Source 2003, 2 http://www.ehjournal.net/content/2/1/10
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bound on the actual incidence of work-related asthma in
this central Massachusetts population of HMO members.
Conclusions
In summary, we demonstrate that computerized HMO
databases (computerized search with manual medical
chart review) can be used successfully to identify and dis-
tinguish between new-onset asthmatics and those with
reactivated disease. This work also demonstrates that pro-
viders attribute most asthma to infection and appear to
ignore the possible contribution of environmental etiolo-
gies (occupational, home, and outdoor exposures) in the
majority of cases. Annualized AOA incidence for the one-
year study period was 3.8 per 1,000 persons for new-onset
cases, 4.6 per 1,000 for reactivation of asthma after at least
one year of inactivity and 8.4 per 1,000 combined.
Approximately 5% of all adult-onset asthma cases were
considered to be associated with work. This is likely an
underestimate given the paucity of evidence that occupa-
tion was consistently evaluated from an etiologic
standpoint.
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